Topical prophylaxis of conjunctivitis induced by high-dose cytosine arabinoside.
Matteucci P
Haematologica. 91(2):255-7.
The anti-human leukocyte antigen-DR monoclonal antibody 1D09C3 activates the mitochondrial cell death pathway and exerts a potent antitumor activity in lymphoma-bearing nonobese diabetic/severe combined immunodeficient mice.
Carlo-Stella C
Cancer Res. 66(3):1799-808.
Skewed T-cell differentiation in patients with indolent non-Hodgkin lymphoma reversed by ex vivo T-cell culture with gammac cytokines.
Anichini A
Blood. 2005 Sep 8;107(2):602-9.
Reduced-intensity conditioning containing low-dose alemtuzumab before allogeneic peripheral blood stem cell transplantation: graft-versus-host disease is decreased but T-cell reconstitution is delayed.
Dodero A
Exp Hematol. 33(8):920-7.
Marked telomere shortening in mobilized peripheral blood progenitor cells (PBPC) following two tightly spaced high-dose chemotherapy courses with G-CSF.
Ricca I
Leukemia. 19(4):644-51.
High response rate and manageable toxicity with an intensive, short-term chemotherapy programme for Burkitt’s lymphoma in adults.
Di Nicola M
Br J Haematol. 126(6):815-20.
Boosting T cell-mediated immunity to tyrosinase by vaccinia virus-transduced, CD34(+)-derived dendritic cell vaccination: a phase I trial in metastatic melanoma.
Di Nicola M
Clin Cancer Res. 10(16):5381-90.
Age- and irradiation-associated loss of bone marrow hematopoietic function in mice is reversed by recombinant human growth hormone.
Carlo-Stella C
Exp Hematol. 32(2):171-8.
Specific histone patterns and acetylase/deacetylase activity at the breakpoint-cluster region of the human MLL gene.
Khobta A, Carlo-Stella C, Capranico G
Cancer Res. 64(8):2656-62.
Use of recombinant human growth hormone (rhGH) plus recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the mobilization and collection of CD34+ cells in poor mobilizers.
Carlo-Stella C
Blood. 2004 Jan 15;103(9):3287-95.